OEM reagents

hs-cTnT is applied for early identification of myocardial injury and rapid diagnosis of acute myocardial infarction in patients with chest pain. hs-cTnT OEM kit utilizes a two-antibody sandwich immunoassay and is applicable to chemiluminescence platforms. Specific antibodies target cTnT epitopes to capture trace plasma hs-cTnT, delivering high sensitivity and specificity. Calibrated with high-purity recombinant cTnT, the assay provides accurate and stable quantitative results. Serving as a key biomarker for acute myocardial infarction diagnosis, it supports early identification and dynamic monitoring of myocardial injury for clinical auxiliary diagnosis. Cardiac Troponin T (cTnT) is a protein encoded by the TNNT2 gene, also known as cardiac troponin T2, the cardiac isoform of troponin T. Located on thin filaments of striated muscle, cTnT regulates muscle contraction in response to intracellular calcium concentration changes. As a primary specific biomarker of cardiomyocyte injury, it exhibits superior specificity, sensitivity and accuracy for the diagnosis of acute myocardial infarction (AMI) compared with other biomarkers. ★Bulk reagents are available with matching raw materials.   

hs-cTnI kit  is applied for early diagnosis and monitoring of myocardial injury and acute myocardial infarction. hs-cTnI OEM kit utilizes a three-antibody sandwich immunoassay and is applicable to chemiluminescence platforms. Specific antibodies target different cTnI epitopes to capture trace plasma hs-cTnI, delivering high sensitivity and specificity. Calibrated with high-purity recombinant cTnI, the assay provides accurate and stable quantitative results. Serving as the gold standard for acute myocardial infarction diagnosis, it supports early identification and dynamic monitoring of myocardial injury for clinical auxiliary diagnosis. Ischemia and hypoxia induce myocardial degeneration and necrosis, enabling cTnI leakage into circulation. Plasma cTnI surges 3–12 hours after injury and remains elevated for over one week. In MI patients, cTnI rises early, peaks at 18 h, and stays abnormal for 6–8 days. As a universally accepted biomarker, cTnI detects myocardial injury and is the gold standard for AMI diagnosis. ★Bulk reagents are available with matching raw materials.

25-OH VD Reagent is used for the in vitro quantitative determination of 25-hydroxyvitamin D in human serum and plasma. Adopting latex turbidimetric assay platforms.  Applicable to clinical labs, it helps diagnose vitamin D deficiency and monitor bone metabolism-related diseases such as osteoporosis. The product requires storage at 2–8°C, featuring stable performance and reliable detection performance for routine clinical testing. ★Bulk reagents are available with matching raw materials.